Neoadjuvant chemotherapy with mFOLFOXIRI alone for cT4 and fixed cT3 rectal cancer: Results from a single arm phase II study (FORTUNE).

Jianwei Zhang,Yue Cai,Huabin Hu,Dianke Chen,Jian Xiao,Jiayu Ling,Wang Wenjing,Ping Lan,Lei Wang,Meijin Huang,Xiaojian Wu,Liang Kang,Jianping Wang,Yanhong Deng

Neoadjuvant chemotherapy with mFOLFOXIRI alone for cT4 and fixed cT3 rectal cancer: Results from a single arm phase II study (FORTUNE).

2017

Jianwei Zhang
Yue Cai
Huabin Hu
Dianke Chen
Jian Xiao
Jiayu Ling
Wang Wenjing
Ping Lan
Lei Wang
Meijin Huang
Xiaojian Wu
Liang Kang
Jianping Wang
Yanhong Deng

3607Background: Although neoadjuvant chemoradiotherapy achieves low local recurrence rates in locally advanced rectal cancer (LARC), it delays administration of systemic chemotherapy. About 30% of ...

Keywords:

Phases of clinical research
General surgery
Physical therapy
Colorectal cancer
Chemotherapy
Medicine
Oncology
neoadjuvant chemoradiotherapy
Internal medicine
locally advanced
systemic chemotherapy
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations